ID   SK-JHRCC-120
AC   CVCL_Z030
DR   Wikidata; Q54953675
RX   PubMed=28753786;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK-JHRCC-120.
CC   Population: Caucasian.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
RX   PubMed=28753786; DOI=10.1016/j.euf.2016.08.005; PMCID=PMC5608640;
RA   Dong, Yi-Yu
RA   Manley, Brandon J.
RA   Becerra, Maria F.
RA   Redzematovic, Almedina
RA   Casuscelli, Jozefina
RA   Tennenbaum, Daniel M.
RA   Reznik, Eduard
RA   Han, Song
RA   Benfante, Nicole E.
RA   Chen, Ying-Bei
RA   Arcila, Maria E.
RA   Aras, Omer
RA   Voss, Martin H.
RA   Feldman, Darren R.
RA   Motzer, Robert J.
RA   Fabbri, Nicola
RA   Healey, John Henry
RA   Boland, Patrick J.
RA   Chawla, Mohit
RA   Durack, Jeremy C.
RA   Lee, Chung-Han
RA   Coleman, Jonathan A.
RA   Russo, Paul
RA   Hakimi, Abraham Ari
RA   Cheng, Emily H.
RA   Hsieh, James J.-D.
RT   "Tumor xenografts of human clear cell renal cell carcinoma but not
RT   corresponding cell lines recapitulate clinical response to sunitinib:
RT   feasibility of using biopsy samples.";
RL   Eur. Urol. Focus 3:590-598(2017).
//